JP2011520855A5 - - Google Patents

Download PDF

Info

Publication number
JP2011520855A5
JP2011520855A5 JP2011509003A JP2011509003A JP2011520855A5 JP 2011520855 A5 JP2011520855 A5 JP 2011520855A5 JP 2011509003 A JP2011509003 A JP 2011509003A JP 2011509003 A JP2011509003 A JP 2011509003A JP 2011520855 A5 JP2011520855 A5 JP 2011520855A5
Authority
JP
Japan
Prior art keywords
composition according
antacid
inflammatory gastrointestinal
subject
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011509003A
Other languages
English (en)
Japanese (ja)
Other versions
JP5769308B2 (ja
JP2011520855A (ja
Filing date
Publication date
Priority claimed from GBGB0808835.3A external-priority patent/GB0808835D0/en
Application filed filed Critical
Publication of JP2011520855A publication Critical patent/JP2011520855A/ja
Publication of JP2011520855A5 publication Critical patent/JP2011520855A5/ja
Application granted granted Critical
Publication of JP5769308B2 publication Critical patent/JP5769308B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011509003A 2008-05-15 2009-05-14 貧血又はｈ．ピロリ感染に用いる単（鉄ヒドロキシピロン）及び組み合わせ（鉄ヒドロキシピロン及び胃腸炎抑止剤）組成物 Active JP5769308B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0808835.3 2008-05-15
GBGB0808835.3A GB0808835D0 (en) 2008-05-15 2008-05-15 Therapeutic compositions
PCT/GB2009/001231 WO2009138761A1 (en) 2008-05-15 2009-05-14 Mono ( iron hydroxypyrone ) and combination ( iron hydroxypyrone and gi inflammation inhibiting agents ) compositions for anaemia or h. pylori infections

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014237229A Division JP2015083572A (ja) 2008-05-15 2014-11-24 鉄ヒドロキシピロンを含む薬剤組成物

Publications (3)

Publication Number Publication Date
JP2011520855A JP2011520855A (ja) 2011-07-21
JP2011520855A5 true JP2011520855A5 (https=) 2012-06-28
JP5769308B2 JP5769308B2 (ja) 2015-08-26

Family

ID=39571409

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011509003A Active JP5769308B2 (ja) 2008-05-15 2009-05-14 貧血又はｈ．ピロリ感染に用いる単（鉄ヒドロキシピロン）及び組み合わせ（鉄ヒドロキシピロン及び胃腸炎抑止剤）組成物
JP2014237229A Pending JP2015083572A (ja) 2008-05-15 2014-11-24 鉄ヒドロキシピロンを含む薬剤組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014237229A Pending JP2015083572A (ja) 2008-05-15 2014-11-24 鉄ヒドロキシピロンを含む薬剤組成物

Country Status (9)

Country Link
US (2) US9248148B2 (https=)
EP (1) EP2303289A1 (https=)
JP (2) JP5769308B2 (https=)
CN (1) CN102099042B (https=)
AU (1) AU2009247762B2 (https=)
CA (1) CA2724172C (https=)
GB (1) GB0808835D0 (https=)
SG (1) SG182137A1 (https=)
WO (1) WO2009138761A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104829272A (zh) 2009-12-22 2015-08-12 拉尔科营养品有限公司 有机螯合的矿物组合物及其制备方法
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
CN104640825A (zh) * 2012-07-05 2015-05-20 拉尔科营养品有限公司(美国) 利用矿物质化合物的农业组合物和应用
US10179120B2 (en) * 2014-01-06 2019-01-15 Iron Therapeutics Holdings Ag Dosage regimen of ferric trimaltol
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
UA117786C2 (uk) 2014-04-17 2018-09-25 Ралко Нутрітіон, Інк. Сільськогосподарські композиції та застосування з використанням мінеральних сполук
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen
WO2016112381A1 (en) 2015-01-09 2016-07-14 The Board Of Trustees Of The University Of Illinois Restoring physiology in iron-deficient organisms using small molecules
JP2017032550A (ja) * 2015-07-30 2017-02-09 大塚製薬株式会社 胃粘膜萎縮の有無を判定する方法
CA3019478C (en) * 2016-03-31 2024-02-13 United Kingdom Research And Innovation Ferric maltol compositions for use in the treatment or prevention of cancer and tumours
GB2553099A (en) * 2016-08-19 2018-02-28 Shield Tx Uk Ltd Use
IT201700021676A1 (it) * 2017-02-28 2018-08-28 Carlo Angelo Ghisalberti Composizioni e sistemi di estrazione del ferro non-eme dalla dieta per uso nell’anemia sideropenica e carenze marziali

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0107458B1 (en) 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
US5177068A (en) 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
AU6010696A (en) 1995-06-10 1997-01-09 Vitra Pharmaceuticals Ltd Iron compounds, compositions, methods of making the same and uses thereof
GB9621273D0 (en) * 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
GB9710699D0 (en) 1997-05-24 1997-07-16 Danbiosyst Uk Gastro-retentive controlled release system
GB0012487D0 (en) 2000-05-24 2000-07-12 Pfylori Limited Use of metal compounds to treat gastrointestinal infections
US7135196B2 (en) * 2000-09-19 2006-11-14 Vitra Pharmaceuticals Limited Iron compositions
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
EP1686982A4 (en) 2003-11-19 2007-03-21 Vecta Ltd METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH HELICOBACTER PYLORI USING COMPOUNDS CONTAINING ENDOPEROXIDE BRIDGE
EP1973549B1 (en) * 2006-01-06 2016-07-20 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
WO2007108712A1 (en) 2006-03-17 2007-09-27 Tatyana Vyacheslavovna Popkova Kit and method for treating or preventing anemia caused by iron deficiency
TW200843802A (en) * 2007-02-09 2008-11-16 Drugtech Corp Compositions for improving gastrointestinal nutrient and drug absorption

Similar Documents

Publication Publication Date Title
JP2011520855A5 (https=)
Wallace et al. Pharmacotherapy of gastric acidity, peptic ulcers and gastroesophageal reflux disease
JP5769308B2 (ja) 貧血又はｈ．ピロリ感染に用いる単（鉄ヒドロキシピロン）及び組み合わせ（鉄ヒドロキシピロン及び胃腸炎抑止剤）組成物
US20080193531A1 (en) Compositions for improving gastrointestinal nutrient and drug absorption
RU2010119041A (ru) Способы лечения нарушений желудочно-кишечного тракта, независимого от потребления пищи
JP2016164165A5 (https=)
RU2017134002A (ru) Стабильные композиции тетрагидробиоптерина
US20030175360A1 (en) Symptomatic relief of gastrointestinal disorders
Salisbury et al. Antacids
MX2009000080A (es) Derivados de bencimidazol como inhibidores selectivos de la bomba de acido.
JP2017200948A5 (https=)
JP2020528888A5 (https=)
EA201100857A1 (ru) Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки
WO2010038241A3 (en) Pharmaceutical compositions comprising of proton pump inhibitor, prokinetic agent and alginic acid
AU2020277247B2 (en) Buffered upper GI absorption promoter
TW201946612A (zh) 醫藥組合物
EA012261B1 (ru) Лекарственные формы, содержащие ингибитор протонного насоса и прокинетический агент
EA200801408A1 (ru) Способы и композиции, применяемые при лечении расстройств желудочно-кишечного тракта
Murakami et al. Tu1056 a phase 3, double-blind study of a triple therapy with TAK-438, amoxicillin, and clarithromycin as first line eradication of H. pylori and a triple therapy with TAK-438, amoxicillin, and metronidazole as second Line eradication of H. pylori
AR044265A1 (es) Una forma de dosificacion que contiene (s) - pantoprazol como ingrediente activo
CA2566655A1 (en) Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2008500365A5 (https=)
Lakshmanan Drugs used in acid peptic disorders
RU2017145941A (ru) Применение органического экстракта цитрусовых с высокой противомикробной активностью и ксилита в качестве системы консервантов в жидкостях, эмульсиях, суспензиях, кремах и антацидах
Scarpignato New drugs to suppress acid secretion: current and future developments